Clinical Trial Update: A Study of Pembrolizumab and Cryoablation in People With Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating pembrolizumab in combination with cryoablation for various breast cancers; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Breast Cancer, Breast Cancer | Phase 1 | Status: RECRUITING